RMD : Summary for ResMed Inc. Common Stock - Yahoo Finance

U.S. Markets closed

ResMed Inc. (RMD)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
63.65+0.75 (+1.19%)
At close: 4:02PM EST
People also watch
VARCOOSTEBCRSTJ
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close62.90
Open63.27
Bid0.00 x
Ask0.00 x
Day's Range63.06 - 63.91
52 Week Range55.13 - 70.90
Volume614,642
Avg. Volume885,850
Market Cap8.97B
Beta0.79
PE Ratio (TTM)25.98
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield1.32 (2.09%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • InPlay from Briefing.com
    Briefing.comyesterday

    InPlay from Briefing.com

    InPlay from Briefing.com

  • PR Newswireyesterday

    ResMed and BMC/3B Medical Settle Global Litigation

    SAN DIEGO, Jan. 21, 2017 /PRNewswire/ -- ResMed (RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time settlement payment to 3B to close the Florida litigation between the two parties.

  • PR Newswireyesterday

    ResMed and BMC/3B Medical Settle Global Litigation

    SAN DIEGO, Jan. 20, 2017 /PRNewswire/ -- ResMed (RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time settlement payment to 3B to close the Florida litigation between the two parties.